• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑铜广泛减少是帕金森病痴呆和阿尔茨海默病痴呆的共同特征。

Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia.

作者信息

Scholefield Melissa, Church Stephanie J, Xu Jingshu, Patassini Stefano, Roncaroli Federico, Hooper Nigel M, Unwin Richard D, Cooper Garth J S

机构信息

Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, Centre for Advanced Discovery & Experimental Therapeutics, School of Medical Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.

Faculty of Science, School of Biological Sciences, University of Auckland, Auckland, New Zealand.

出版信息

Front Aging Neurosci. 2021 Mar 3;13:641222. doi: 10.3389/fnagi.2021.641222. eCollection 2021.

DOI:10.3389/fnagi.2021.641222
PMID:33746735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7966713/
Abstract

Several studies of Parkinson's disease (PD) have reported dysregulation of cerebral metals, particularly decreases in copper and increases in iron in substantia nigra (SN). However, few studies have investigated regions outside the SN, fewer have measured levels of multiple metals across different regions within the same brains, and there are no currently-available reports of metal levels in Parkinson's disease dementia (PDD). This study aimed to compare concentrations of nine essential metals across nine different brain regions in cases of PDD and controls. Investigated were: primary motor cortex (MCX); cingulate gyrus (CG); primary visual cortex (PVC); hippocampus (HP); cerebellar cortex (CB); SN; locus coeruleus (LC); medulla oblongata (MED); and middle temporal gyrus (MTG), thus covering regions with severe, moderate, or low levels of neuronal loss in PDD. Levels of eight essential metals and selenium were determined using an analytical methodology involving the use of inductively-coupled plasma mass spectrometry (ICP-MS), and compared between cases and controls, to better understand the extent and severity of metal perturbations. Findings were also compared with those from our previous study of sporadic Alzheimer's disease dementia (ADD), which employed equivalent methods, to identify differences and similarities between these conditions. Widespread copper decreases occurred in PDD in seven of nine regions (exceptions being LC and CB). Four PDD-affected regions showed similar decreases in ADD: CG, HP, MTG, and MCX. Decreases in potassium and manganese were present in HP, MTG and MCX; decreased manganese was also found in SN and MED. Decreased selenium and magnesium were present in MCX, and decreased zinc in HP. There was no evidence for increased iron in SN or any other region. These results identify alterations in levels of several metals across multiple regions of PDD brain, the commonest being widespread decreases in copper that closely resemble those in ADD, pointing to similar disease mechanisms in both dementias.

摘要

多项关于帕金森病(PD)的研究报告称,大脑中的金属元素失调,尤其是黑质(SN)中铜含量降低、铁含量升高。然而,很少有研究对黑质以外的区域进行调查,更少有人在同一大脑的不同区域测量多种金属的含量,目前也没有关于帕金森病痴呆(PDD)患者金属含量的报告。本研究旨在比较PDD患者和对照组九个不同脑区中九种必需金属的浓度。研究的脑区包括:初级运动皮层(MCX);扣带回(CG);初级视觉皮层(PVC);海马体(HP);小脑皮层(CB);黑质(SN);蓝斑(LC);延髓(MED);以及颞中回(MTG),从而覆盖了PDD中神经元损失程度严重、中度或轻度的区域。使用电感耦合等离子体质谱法(ICP-MS)的分析方法测定了八种必需金属和硒的含量,并在病例组和对照组之间进行比较,以更好地了解金属紊乱的程度和严重性。研究结果还与我们之前采用相同方法对散发性阿尔茨海默病痴呆(ADD)的研究结果进行了比较,以确定这两种疾病之间的异同。PDD患者九个区域中的七个区域出现了广泛的铜含量降低(LC和CB除外)。四个受PDD影响的区域在ADD中也出现了类似的降低:CG、HP、MTG和MCX。HP、MTG和MCX中钾和锰含量降低;SN和MED中也发现锰含量降低。MCX中硒和镁含量降低,HP中锌含量降低。没有证据表明SN或任何其他区域的铁含量增加。这些结果表明,PDD患者大脑多个区域的几种金属含量发生了变化,最常见的是广泛的铜含量降低,这与ADD中的情况非常相似,表明这两种痴呆症存在相似的疾病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb35/7966713/b0848ae2b2aa/fnagi-13-641222-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb35/7966713/f03bb68e9b25/fnagi-13-641222-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb35/7966713/628249e5e372/fnagi-13-641222-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb35/7966713/b0848ae2b2aa/fnagi-13-641222-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb35/7966713/f03bb68e9b25/fnagi-13-641222-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb35/7966713/628249e5e372/fnagi-13-641222-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb35/7966713/b0848ae2b2aa/fnagi-13-641222-g0003.jpg

相似文献

1
Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia.脑铜广泛减少是帕金森病痴呆和阿尔茨海默病痴呆的共同特征。
Front Aging Neurosci. 2021 Mar 3;13:641222. doi: 10.3389/fnagi.2021.641222. eCollection 2021.
2
Severe and Regionally Widespread Increases in Tissue Urea in the Human Brain Represent a Novel Finding of Pathogenic Potential in Parkinson's Disease Dementia.人脑组织中尿素严重且广泛区域性增加是帕金森病痴呆症致病潜力的一项新发现。
Front Mol Neurosci. 2021 Oct 22;14:711396. doi: 10.3389/fnmol.2021.711396. eCollection 2021.
3
Metallomic analysis of brain tissues distinguishes between cases of dementia with Lewy bodies, Alzheimer's disease, and Parkinson's disease dementia.脑组织的金属组学分析可区分路易体痴呆、阿尔茨海默病和帕金森病痴呆病例。
Front Neurosci. 2024 Jun 26;18:1412356. doi: 10.3389/fnins.2024.1412356. eCollection 2024.
4
Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson's Disease Dementia.帕金森病痴呆患者大脑多个区域泛酸(维生素B5)水平显著降低。
Metabolites. 2021 Aug 25;11(9):569. doi: 10.3390/metabo11090569.
5
Perturbations in levels of essential metals less severe in Parkinson's disease without dementia than in Parkinson's disease dementia.与帕金森病痴呆相比,无痴呆的帕金森病患者体内必需金属水平的扰动较轻。
Metallomics. 2025 Mar 7;17(3). doi: 10.1093/mtomcs/mfaf006.
6
Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain.路易体痴呆症大脑中普遍存在局部泛酸(维生素 B5)减少。
J Parkinsons Dis. 2024;14(5):965-976. doi: 10.3233/JPD-240075.
7
Plasma metals as potential biomarkers in dementia: a case-control study in patients with sporadic Alzheimer's disease.血浆金属作为痴呆症的潜在生物标志物:散发性阿尔茨海默病患者的病例对照研究。
Biometals. 2018 Apr;31(2):267-276. doi: 10.1007/s10534-018-0089-3. Epub 2018 Mar 7.
8
Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia.阿尔茨海默病患者大脑广泛存在严重铜缺乏的证据。
Metallomics. 2017 Aug 16;9(8):1106-1119. doi: 10.1039/c7mt00074j.
9
Widespread selenium deficiency in the brain of cases with Huntington's disease presents a new potential therapeutic target.亨廷顿病患者大脑中普遍存在的硒缺乏为新的潜在治疗靶点。
EBioMedicine. 2023 Nov;97:104824. doi: 10.1016/j.ebiom.2023.104824. Epub 2023 Oct 10.
10
Multi-regional alterations in glucose and purine metabolic pathways in the Parkinson's disease dementia brain.帕金森病痴呆大脑中葡萄糖和嘌呤代谢途径的多区域改变。
NPJ Parkinsons Dis. 2023 Apr 20;9(1):66. doi: 10.1038/s41531-023-00488-y.

引用本文的文献

1
Perturbations in levels of essential metals less severe in Parkinson's disease without dementia than in Parkinson's disease dementia.与帕金森病痴呆相比,无痴呆的帕金森病患者体内必需金属水平的扰动较轻。
Metallomics. 2025 Mar 7;17(3). doi: 10.1093/mtomcs/mfaf006.
2
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.神经退行性疾病中铁及其他金属离子的稳态与代谢
Signal Transduct Target Ther. 2025 Feb 3;10(1):31. doi: 10.1038/s41392-024-02071-0.
3
Magnesium (Mg) and Neurodegeneration: A Comprehensive Overview of Studies on Mg Levels in Biological Specimens in Humans Affected Some Neurodegenerative Disorders with an Update on Therapy and Clinical Trials Supplemented with Selected Animal Studies.

本文引用的文献

1
Evidence that levels of nine essential metals in post-mortem human-Alzheimer's-brain and ex vivo rat-brain tissues are unaffected by differences in post-mortem delay, age, disease staging, and brain bank location.有证据表明,在死后人类阿尔茨海默病大脑和离体大鼠大脑组织中,九种必需金属的水平不受死后延迟、年龄、疾病分期和脑库位置差异的影响。
Metallomics. 2020 Jun 24;12(6):952-962. doi: 10.1039/d0mt00048e.
2
Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant?铜离子与帕金森病:为何体内平衡如此重要?
Biomolecules. 2020 Jan 29;10(2):195. doi: 10.3390/biom10020195.
3
Iron concentrations in neurons and glial cells with estimates on ferritin concentrations.
镁(Mg)与神经退行性变:对受某些神经退行性疾病影响的人类生物样本中镁水平研究的全面综述,包括治疗进展及临床试验,并辅以精选的动物研究。
Int J Mol Sci. 2024 Nov 23;25(23):12595. doi: 10.3390/ijms252312595.
4
Copper homeostasis and neurodegenerative diseases.铜稳态与神经退行性疾病
Neural Regen Res. 2025 Nov 1;20(11):3124-3143. doi: 10.4103/NRR.NRR-D-24-00642. Epub 2024 Nov 13.
5
Copper-mediated neurotoxicity and genetic vulnerability in the background of neurodegenerative diseases in C. elegans.铜介导的神经毒性和神经退行性疾病背景下秀丽隐杆线虫的遗传易感性。
Toxicol Sci. 2024 Oct 1;201(2):254-262. doi: 10.1093/toxsci/kfae092.
6
Role of copper in central nervous system physiology and pathology.铜在中枢神经系统生理与病理中的作用。
Neural Regen Res. 2025 Apr 1;20(4):1058-1068. doi: 10.4103/NRR.NRR-D-24-00110. Epub 2024 May 17.
7
Metallomic analysis of brain tissues distinguishes between cases of dementia with Lewy bodies, Alzheimer's disease, and Parkinson's disease dementia.脑组织的金属组学分析可区分路易体痴呆、阿尔茨海默病和帕金森病痴呆病例。
Front Neurosci. 2024 Jun 26;18:1412356. doi: 10.3389/fnins.2024.1412356. eCollection 2024.
8
Mechanism of Cu entry into the brain: many unanswered questions.铜进入大脑的机制:诸多未解之谜。
Neural Regen Res. 2024 Nov 1;19(11):2421-2429. doi: 10.4103/1673-5374.393107. Epub 2024 Jan 8.
9
Widespread selenium deficiency in the brain of cases with Huntington's disease presents a new potential therapeutic target.亨廷顿病患者大脑中普遍存在的硒缺乏为新的潜在治疗靶点。
EBioMedicine. 2023 Nov;97:104824. doi: 10.1016/j.ebiom.2023.104824. Epub 2023 Oct 10.
10
What Dietary Vitamins and Minerals Might Be Protective against Parkinson's Disease?哪些膳食维生素和矿物质可能对帕金森病有保护作用?
Brain Sci. 2023 Jul 24;13(7):1119. doi: 10.3390/brainsci13071119.
神经元和神经胶质细胞中的铁浓度及对铁蛋白浓度的估计。
BMC Neurosci. 2019 May 29;20(1):25. doi: 10.1186/s12868-019-0507-7.
4
Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology.铁、髓鞘和大脑:神经影像学与神经生物学的交汇。
Trends Neurosci. 2019 Jun;42(6):384-401. doi: 10.1016/j.tins.2019.03.009. Epub 2019 Apr 29.
5
Parkinson's disease: Mechanisms, translational models and management strategies.帕金森病:发病机制、转化模型及管理策略。
Life Sci. 2019 Jun 1;226:77-90. doi: 10.1016/j.lfs.2019.03.057. Epub 2019 Apr 10.
6
Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation.致力于发现和开发有效的α-突触核蛋白淀粉样聚集调节剂。
Eur J Med Chem. 2019 Apr 1;167:10-36. doi: 10.1016/j.ejmech.2019.01.045. Epub 2019 Jan 28.
7
Regional protein expression in human Alzheimer's brain correlates with disease severity.人脑阿尔茨海默病中区域蛋白的表达与疾病严重程度相关。
Commun Biol. 2019 Feb 4;2:43. doi: 10.1038/s42003-018-0254-9. eCollection 2019.
8
The Role of Lipids in Parkinson's Disease.脂质在帕金森病中的作用。
Cells. 2019 Jan 7;8(1):27. doi: 10.3390/cells8010027.
9
Role of Autophagy in Parkinson's Disease.自噬在帕金森病中的作用。
Curr Med Chem. 2019;26(20):3702-3718. doi: 10.2174/0929867325666180226094351.
10
Metals and Parkinson's Disease: Mechanisms and Biochemical Processes.金属与帕金森病:机制与生化过程。
Curr Med Chem. 2018;25(19):2198-2214. doi: 10.2174/0929867325666171129124616.